Agilent Technologies and Maxim Biotech Work Together to Provide Easier, Quicker and More Accurate Gene Analysis.Business Editors/High-Tech Writers PALO ALTO Palo Alto, city, California Palo Alto (păl`ō ăl`tō), city (1990 pop. 55,900), Santa Clara co., W Calif.; inc. 1894. Although primarily residential, Palo Alto has aerospace, electronics, and advanced research industries. , Calif. & SOUTH SAN FRANCISCO South San Francisco, city (1990 pop. 54,312), San Mateo co., W Calif.; inc. 1908. South San Francisco has several industrial parks; its manufactures include medical supplies and equipment, foods, paint, paper products, consumer goods, and clothing. , Calif.--(BUSINESS WIRE)--Aug. 1, 2001--Agilent Technologies Inc. (NYSE NYSE See: New York Stock Exchange :A) and Maxim Biotech Inc. today announced a co-marketing agreement involving Agilent's 2100 Bioanalyzer with DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. LabChip(R) kits and Maxim Biotech's multiplex PCR PCR polymerase chain reaction. PCR abbr. polymerase chain reaction Polymerase chain reaction (PCR) (MPCR MPCR Multiplex Polymerase Chain Reaction MPCR Mouvement du Peuple Congolais pour la République (French) MPCR Master Product & Control Record MPCR Memorandum Program Change Request ) reagents. This combination of products provides biochemists with the ability to more easily, quickly, and accurately conduct experiments involving the analysis of several genes. The DNA LabChip kits are developed and manufactured by Caliper caliper Instrument that consists of two adjustable legs or jaws for measuring the dimensions of material parts. Spring calipers have an adjusting screw and nut; firm-joint calipers use friction at the joint to hold the legs unmoving. Technologies Corp. (Nasdaq:CALP CALP Cognitive Academic Language Proficiency CALP Cristalleria Artistica La Piana (All the World, Crystalware) CALP Calsenilin-Like Protein CALP Centro de Astrofísica en la Palma (Canary Islands, Spain) ), Agilent's collaboration partner in the Lab-on-a-Chip business. The DNA 1000 LabChip kit has been specially designed to meet the needs of multiplex PCR product analysis with an ideal sizing range and high sensitivity. The co-marketing activities between Agilent and Maxim Biotech will allow both companies to share in direct marketing, conduct market research and publicize Agilent's Lab-on-a-Chip and Maxim Biotech's PCR products. The companies will also work together to ensure compatibility of their products and provide user documentation in the form of application notes. "A key advantage of the LabChip technology for PCR product analysis is the capability to quantify many gene targets in a single reaction," said Bill Buffington, vice president and general manager of Agilent's Life Science Business Unit. "By combining these products, customers can simultaneously and quantitatively analyze gene expression of many targets. In addition, the amount of biological material required for the analysis is significantly reduced when compared to other methods, which is particularly important when only a small amount of material is available." "At Maxim Biotech, we use the Agilent 2100 Bioanalyzer to control quality for all of our MPCR reagents because it is significantly easier to operate and gives more objective results than the alternative gel electrophoresis method," said Joe Ma, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Maxim Biotech. "By using the Agilent 2100 Bioanalyzer in conjunction with our MPCR kits, customers can reduce the volume of the PCR reagents they need to use because of the sensitivity of the DNA 1000 LabChip kit, thereby running more experiments with each kit. Furthermore, the 2100 Bioanalyzer generates electronic data records, saving time and allowing researchers to more easily quantify their target genes. We are excited about the opportunity to co-market our products with Agilent." About Maxim Biotech, Inc. Maxim Biotech, Inc. is a leader in multiplex polymerase chain reaction polymerase chain reaction (pŏl`ĭmərās') (PCR), laboratory process in which a particular DNA segment from a mixture of DNA chains is rapidly replicated, producing a large, readily analyzed sample of a piece of DNA; the process is (MPCR) technology. Maxim designs, manufactures, and commercializes MPCR optimization and application kits that enable multiple genes amplification in a single PCR reaction. The MPCR system is designed to accelerate laboratory experimentation and has potential applicability in a broad range of industries including pharmaceuticals, agriculture, and molecular diagnostics. Maxim has established multiple strategic and commercial alliances and has built a leading intellectual property estate in MPCR technology. Information about Maxim Biotech, Inc. can be found on the Web at www.maximbio.com. About Agilent Technologies Agilent Technologies Inc. (NYSE:A) is a global technology leader in communications, electronics, life sciences and healthcare. The company's 48,000 employees serve customers in more than 120 countries. Agilent had net revenue of $9.4 billion in fiscal year 2000, as restated to reflect the pending sale of its healthcare business. Information about Agilent Technologies can be found on the Web at www.agilent.com. Note to Editors: Caliper(R), LabChip(R), and the LabChip logo are U.S. registered trademarks of Caliper Technologies Corp. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion